Selected Publications
Mascarenhas, John O, Rampal, Raajit K, Kosiorek, Heidi E, Bhave, Rupali, Hexner, Elizabeth, Wang, Eunice S, Gerds, Aaron, Abboud, Camille N, Kremyanskaya, Marina, Berenzon, Dimitry, Odenike, Olatoyosi, Farnoud, Noushin, Krishnan, Aishwarya, Weinberg, Rona Singer, McGovern, Erin, Salama, Mohamed E, Najfeld, Vesna, Medina-Martinez, Juan S, Arango Ossa, Juan E, Levine, Max F, Zhou, Yangyu, Sandy, Lonette, Heaney, Mark L, Levine, Ross L, Mesa, Ruben A, Dueck, Amylou C, Hoffman, Ronald: Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase. Blood advances 4 (20): 5246-5256,2020.
Stadtmauer EA, Fraietta JA, Davis MM, Cohen AD, Weber KL, Lancaster E, Mangan PA, Kulikovskaya I, Gupta M, Chen F, Tian L, Gonzalez VE, Xu J, Jung IY, Melenhorst JJ, Plesa G, Shea J, Matlawski T, Cervini A, Gaymon AL, Desjardins S, Lamontagne A, Salas-Mckee J, Fesnak A, Siegel DL, Levine BL, Jadlowsky JK, Young RM, Chew A, Hwang WT, Hexner EO, Carreno BM, Nobles CL, Bushman FD, Parker KR, Qi Y, Satpathy AT, Chang HY, Zhao Y, Lacey SF, June CH.: CRISPR-engineered T cells in patients with refractory cancer. Science : 2020.
Kim GYG, Burns J, Freyer CW, Hamilton KW, Frey NV, Gill SI, Hexner EO, Luger SM, Mangan JK, Martin ME, McCurdy SR, Perl AE, Porter DL, Schuster MG, Stadtmauer EA, Loren AW.: Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. Am J Hematol. : 2020.
Aziz MD, Shah J, Kapoor U, Dimopoulos C, Anand S, Augustine A, Ayuk F, Chaudhry M, Chen YB, Choe HK, Etra A, Gergoudis S, Hartwell MJ, Hexner EO, Hogan WJ, Kitko CL, Kowalyk S, Kröger N, Merli P, Morales G, Nakamura R, Ordemann R, Pulsipher MA, Qayed M, Reshef R, Rösler W, Schechter T, Schreiner E, Srinagesh H, Wölfl M, Wudhikarn K, Yanik G, Young R, Özbek U, Ferrara JLM, Levine JE.: Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant Leukemia : 2020.
Frey, Noelle V, Shaw, Pamela A, Hexner, Elizabeth O, Pequignot, Edward, Gill, Saar, Luger, Selina M, Mangan, James K, Loren, Alison W, Perl, Alexander E, Maude, Shannon L, Grupp, Stephan A, Shah, Nirav N, Gilmore, Joan, Lacey, Simon F, Melenhorst, Jos J, Levine, Bruce L, June, Carl H, Porter, David L: Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (5): 415-422,2020.
Aziz, Mina D, Shah, Jay, Kapoor, Urvi, Dimopoulos, Christina, Anand, Sarah, Augustine, Allan, Ayuk, Francis, Chaudhry, Mohammed, Chen, Yi-Bin, Choe, Hannah K, Etra, Aaron, Gergoudis, Stephanie, Hartwell, Matthew J, Hexner, Elizabeth O, Hogan, William J, Kitko, Carrie L, Kowalyk, Steven, Kröger, Nicolaus, Merli, Pietro, Morales, George, Nakamura, Ryotaro, Ordemann, Rainer, Pulsipher, Michael A, Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Schreiner, Elisabeth, Srinagesh, Hrishikesh, Wölfl, Matthias, Wudhikarn, Kitsada, Yanik, Gregory, Young, Rachel, Özbek, Umut, Ferrara, James L M, Levine, John E: Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant. Leukemia 34 (7): 1898-1906,2020.
Freyer, Craig W, Carulli, Alison, Ganetsky, Alex, Hughes, Mitchell E, Krause, Tracy M, Timlin, Colleen, Frey, Noelle V, Gill, Saar I, Hexner, Elizabeth O, Loren, Alison W, Mangan, James K, Martin, Mary Ellen, McCurdy, Shannon R, Perl, Alexander E, Pratz, Keith, Porter, David L, Luger, Selina M: Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leukemia & lymphoma 61 (9): 2200-2207,2020.
Gerds, Aaron T, Gotlib, Jason, Bose, Prithviraj, Deininger, Michael W, Dunbar, Andrew, Elshoury, Amro, George, Tracy I, Gojo, Ivana, Gundabolu, Krishna, Hexner, Elizabeth, Hobbs, Gabriela, Jain, Tania, Jamieson, Catriona, Kuykendall, Andrew T, McMahon, Brandon, Mohan, Sanjay R, Oehler, Vivian, Oh, Stephen, Pardanani, Animesh, Podoltsev, Nikolai, Ranheim, Erik, Rein, Lindsay, Salit, Rachel, Snyder, David S, Stein, Brady L, Talpaz, Moshe, Thota, Swapna, Vachhani, Pankit, Wadleigh, Martha, Walsh, Katherine, Ward, Dawn C, Bergman, Mary Anne, Sundar, Hema: Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN 18 (9): 1248-1269,2020.
Frey, Noelle V, Gill, Saar, Hexner, Elizabeth O, Schuster, Stephen, Nasta, Sunita, Loren, Alison, Svoboda, Jakub, Stadtmauer, Edward, Landsburg, Daniel J, Mato, Anthony, Levine, Bruce L, Lacey, Simon F, Melenhorst, Jan Joseph, Veloso, Elizabeth, Gaymon, Avery, Pequignot, Edward, Shan, Xinhe, Hwang, Wei-Ting, June, Carl H, Porter, David L: Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (25): 2862-2871,2020.
Tian, Yuanyuan, Meng, Lijun, Wang, Ying, Li, Bohan, Yu, Hongshuang, Zhou, Yan, Bui, Tien, Li, Alicia, Abraham, Ciril, Zhang, Yongping, Wang, Jian, Zhao, Chenchen, Mineishi, Shin, Gallucci, Stefania, Porter, David, Hexner, Elizabeth, Zheng, Hong, Zhang, Yanyun, Hu, Shaoyan, Zhang, Yi: Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction. The Journal of clinical investigation : 2020.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-151
3400 Civic Center Boulevard
Philadelphia,
PA
19104
Phone: 215-614-1847
Patient appointments: 800-789-7366